Published in Breast Cancer Res Treat on January 01, 2004
Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes. | NCT00711529
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39
Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol (2009) 1.04
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol (2009) 1.00
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus (2015) 0.82
A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia (2010) 0.80
Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study. BMJ Open (2013) 0.79
A practical guide to the management of menopausal symptoms in breast cancer patients. Support Care Cancer (2005) 0.78
How are Interactions Taken into Account in Studies on Conventional and Complementary Therapies for Breast Cancer Patients with Menopausal Complaints? Geburtshilfe Frauenheilkd (2012) 0.75
The effect of gabapentin on intensity and duration of hot flashes in postmenopausal women: a randomized controlled trial. Glob J Health Sci (2013) 0.75
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol (2012) 6.78
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol (2010) 6.39
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97
Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol (2012) 4.41
Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol (2012) 3.03
Use of radioactive iodine for thyroid cancer. JAMA (2011) 2.98
Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA (2009) 2.64
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39
Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25
Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst (2009) 2.18
Latina patient perspectives about informed treatment decision making for breast cancer. Patient Educ Couns (2008) 2.17
Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol (2006) 2.01
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
Patient-centered care and breast cancer survivors' satisfaction with information. Patient Educ Couns (2005) 1.88
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst (2011) 1.69
A phase I weekly dosing study of brentuximab vedotin in patients with relapsed/refractory CD30-positive hematologic malignancies. Clin Cancer Res (2011) 1.67
Racial/ethnic differences in adequacy of information and support for women with breast cancer. Cancer (2008) 1.64
Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. Int J Cancer (2005) 1.63
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol (2003) 1.63
Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst (2009) 1.56
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma. J Clin Oncol (2009) 1.52
Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer (2001) 1.52
Cancer-related fatigue and sleep disorders. Oncologist (2007) 1.47
Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv (2009) 1.47
Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol (2013) 1.46
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma. Br J Haematol (2009) 1.44
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43
Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress (2002) 1.40
Acustimulation wristbands for the relief of chemotherapy-induced nausea. Altern Ther Health Med (2002) 1.39
Fatigue associated with cancer and its treatment. Support Care Cancer (2001) 1.38
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther (2004) 1.37
Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36
An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32
Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol (2005) 1.32
Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies. Blood (2007) 1.29
Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28
Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer (2004) 1.28
Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer (2009) 1.28
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26
Management of cancer-related fatigue. Cancer Invest (2005) 1.26
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer (2012) 1.25
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24
Perceived discrimination, psychological distress, and current smoking status: results from the Behavioral Risk Factor Surveillance System Reactions to Race module, 2004-2008. Am J Public Health (2012) 1.23
Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer. Breast Cancer Res Treat (2013) 1.21
Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Qual Saf (2011) 1.21
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat (2009) 1.19
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. J Hematol Oncol (2014) 1.18
Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer. Med Care (2010) 1.18
The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer (2012) 1.17
Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer. Med Care (2010) 1.16
Variation in the management of thyroid cancer. J Clin Endocrinol Metab (2013) 1.15
Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol (2012) 1.15
Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program. Support Cancer Ther (2004) 1.14
The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage (2003) 1.13
Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13
A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther (2007) 1.13
Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology (2005) 1.13
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer (2013) 1.12
Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol (2010) 1.12
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol (2009) 1.11
Individualized strategy for dosing luteinizing hormone-releasing hormone agonists for androgen-independent prostate cancer: identification of outcomes and costs. J Oncol Pract (2006) 1.11
Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer (2011) 1.11
The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol (2011) 1.11
Anticipatory nausea and vomiting. Support Care Cancer (2010) 1.09
Employment of nurse practitioners and physician assistants in breast cancer care. J Oncol Pract (2010) 1.08
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07
Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer (2011) 1.07
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. Cancer (2011) 1.07
The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol Immunother (2011) 1.06
Racial/ethnic differences in job loss for women with breast cancer. J Cancer Surviv (2010) 1.06
CD30: an important new target in hematologic malignancies. Leuk Lymphoma (2011) 1.05